| 2.00-3.00 PM | Registration | |
| 3.00 PM | Introduction | |
| Session: I | ||
| Chair: Dr V P Chaudhary & Dr H P Pati | ||
| 3.05-3.25 PM | Chemo-free treatment in myeloid malignancies | Dr. Pravas Mishra, Faridabad |
| 3.25-3.50 PM | Laboratory approach to diagnosis of VWD – Choosing wisely | Dr. Pankhi Dutta, Dubai, UAE |
| Session: II Controversies in Hematology | ||
| Chair: Dr Rajat Kumar & Dr M Mahapatra | ||
| 3.50-4.20 PM | DEBATE-ABVD continues to be frontline standard of care for Hodgkin Lymphoma – For AND Against | |
| For ABVD | Dr. Tuphan Kanti Dolai, Kolkata | |
| Against ABVD | Dr. Asish Dixit, Bengaluru | |
| 4.20-5.00 | Alumni Photo Session & Tea Break | |
| Session: III (Controversies in Hematology) | ||
| Chair: Dr Renu Saxena, Dr Jasjeet Singh | ||
| 5.00-5.30 PM | DEBATE: Morphology is obsolete in genomic era for the diagnosis of AML/MDS | |
| In favour | Dr. Sanjeev Gupta, Delhi | |
| Against | Dr. Ankur Ahuja, Pune | |
| Session: IV Learning from “One of my most memorable case” | ||
| Chair: Dr Tulika Seth, | ||
| 5.30-5.45 PM | Dr. D K Mishra, Kolkata | |
| 5.45-6.00 PM | Dr. Prantar Chakrabarti, Kolkata | |
| 6.00-6.15 PM | Dr. Maitreyee Bhattacharya, Kolkata | |
| 6.15-6.30 PM | Dr. Narendra Agrawal, Delhi | |
| 6.30-6.45 PM | Dr. Abhishek Purohit, Jodhpur | |
| 6.45 PM | Break | |
| 7.00 PM onwards | Alumni Dinner at Faculty Club Lawn |
| 8.00 AM onwards | Registration | ||
| 8.00-9.00 AM | QUIZ Quiz Masters- Dr. Narasimhapriyan Kannan, Mumbai and Dr. Sumeet Mirgh, Mumbai | ||
| 9.00-9.50 AM | Session V: Session on CML Sponsor: Novartis Chair: Dr. Sudha Sazawal, Delhi; Dr. Silky Jain, Noida | ||
| 9.00-9.25 AM | Evolving treatment goals for CML: Are we there yet with regards to TFR and QoL? | Dr. Naveen Gupta, Jaipur (20+5 min) | |
| 9.25-9.50 AM | Targeting the treatment gaps in 2+L CML | Dr. Sanjeev Kumar Sharma, Delhi (20+5 min) | |
| 9.50-10.30 AM | Session VI: Session on Myeloproliferative Neoplasms Chairpersons- Dr. Ankur Jain, Delhi; Dr. Amrita Saraf, Delhi; Dr. Sarika Singh, Delhi | ||
| 9.50-10.10 | Role of JAK2 inhibitors in MF and beyond | Dr. Rajiv Kumar, Delhi | |
| 10.10-10.30 | Transplantation in Myelofibrosis – special considerations | Dr. Rajat Kumar, Toronto, Canada | |
| 10.30-11.00 |
Breakfast and Tea |
||
| 11.00-11.45 AM | Session: VII: Session on Bone marrow failure Chair: Dr. Anil Kumar Tripathi, Lucknow; Dr. Sumita Chaudhary, Delhi; Dr. Aditya Kumar Gupta, Delhi | ||
| 11.00-11.15 AM | CRISPR in diagnostics in hematological malignancies | Dr. Syed Hasan, Mumbai | |
| 11.15-11.45 AM | IST for AA – bridging the gap with generics | Dr. Soniya Nityanand, Lucknow | |
| 11.45- 12.45 PM | Session VIII: Session on Acute Lymphoblastic Leukemia
Chair: Dr. Deepti Mutreja, Bengaluru; Dr. Monica Gupta, Delhi; Dr. Akash Kumar Jha, Delhi Sponsor- Pfizer |
||
| 11:45-12:05 | Incorporating Novel agents in relapsed/ refractory ALL management | Dr. Dinesh Bhurani, Delhi (20 minutes) | |
| 12:05-12:25 | Measurable residual disease assessment in a patient treated with anti-CD19 & anti-CD22 – CD 22 agents | Dr. Narender Tejwani, Delhi (15 minutes) | |
| 12:25-12:45 | Laboratory assessment following CAR–T therapy | Dr. Aastha Gupta, Delhi (15 minutes) | |
| 12.45-1.15 | Session IX: Learning through an interesting case (Panel discussion) | ||
| Dr. Jasmita Dass/Dr. Pradeep Kumar (APML+CML) |
|
||
| 1.15-2.15 PM |
LUNCH |
||
| 2.15- 3.15 PM | Session: X: Session on Plasma Cell Disorders Chair: Dr. Mitu Shrikhande, Delhi; Dr. Sonal Jain, Gurugram; Dr. Sunil Gupta, Hyderabad; Dr. Rayaz Ahmed, Delhi Sponsor- Johnson & Johnson | ||
| 2:15-2:35 PM | Monoclonal gammopathies of clinical significance | Dr. Venkatesan Somasundaram, Pune | |
| 2:35-2:55 PM | Impact of Bi –specific antibodies in R/R Myeloma in the Indian setting | Dr. Pankaj Malhotra, Chandigarh | |
| 2:55-3:15 PM | Smoldering myeloma – treat or not to treat | Dr. Dharma Chaudhary, Delhi | |
| 3.15-4.30 PM | Session XI: Acute Leukemia Chair: Dr. Tarun Verma, Delhi; Dr. Anita Chopra, Delhi; Dr. Govind Patel, Jodhpur Sponsor: Astellas Oncology | ||
| 3.15-3.30 PM | Case-based discussion for ICC vs WHO classification for AML/MDS | Dr. Rakhee Kar, Puducherry | |
| 3.30-3.45 PM | Single-cell sequencing in AML | Dr. Ritu Gupta, Delhi | |
| 3.45-4.00 PM | Exploring CAR-T Beyond All and Lymphoma | Dr. Rahul Naithani, Gurugram | |
| 4.00-4.15 PM | Targeted therapies for Relapsed AML | Dr. Amrita Ramaswami, Delhi | |
| 4.15-4.30 PM | Discussion | ||
| 4.30-4.50 PM | Tea | ||
| 4.50 -5.20 PM | Session XII: Learning through interesting case (Panel discussion) | ||
| Dr. Mukul Aggarwal, Delhi/ Dr. Richa Chauhan, Delhi |
|
||
| 5.20 – 6.40 PM | Session: XIII: RESIDENT’S CORNER (Atypical case-based discussion 8 min + 2 min) | ||
| AIIMS, Rishikesh | Dr. Uttam Nath, Rishikesh | ||
| AIIMS, Bhubaneswar | Dr. Prabodha Kumar Das, Bhubaneswar | ||
| CMC, Vellore | Dr. Aby Abraham, Vellore | ||
| PGIMER, Chandigarh | Dr. Alka Khadwal, Chandigarh | ||
| SGPGI, Lucknow | Dr. Sanjeev Yadav, Lucknow | ||
| AIIMS New, Delhi | Dr. Rishi Dhawan, Delhi | ||
| 7. 00 PM onwards | Banquet Dinner at swimming pool Lawn | ||
| 8.30- 9.00 AM |
QUIZ Quiz masters: Dr. Gurmeet Singh, Bhilai and Dr. Amiya Ranjan Nayak, Cuttack |
||
| 9.00-10.00 AM | Session: XIV: Session on Hemoglobinopathies and Sickle Cell Disease Chair: Dr. Jitender Mohan Khunger, Delhi; Dr. Sunita Sharma, Delhi, Dr. Vijay Kumar, Delhi | ||
| Newer techniques for the diagnosis of thalassemia, including POCTs | Dr. Ruchi Gupta, Lucknow | ||
|
Exploiting iron homeostasis and red cell life cycle in hematological disorders |
Dr. Prashant Sharma, Chandigarh | ||
| Therapies and New Concepts for SCD in the last 5 years- hope or hype | Dr. Rabindra Kumar Jena, Cuttack | ||
| 10.00-10.30 AM |
Break for breakfast |
||
| Session on AML/MDS | |||
| 10.30-11.15 | Session XV: Session on AML/ MDS
Chair: Dr. Tathagata Chatterjee, Faridabad; Dr. Rekha Chaubey, Delhi; Dr. Sudha Sethy, Cuttack Sponsor: Intas |
||
| Minimum molecular workup for resource-constrained and resource-unlimited settings- what and how | Dr. Neha Singh, Varanasi | ||
| Treatment of a case of low-risk MDS- what’s changed | Dr. Divya Bansal, Delhi | ||
| 11.15-12.00 PM | Session XVI: Session on AML Chair: Dr. Jyoti Bajaj, Ahmedabad; Dr. Bhushan Asthana, Pune | ||
| Selecting and investigating for an underlying germline predisposition disorder in AML/ MDS- A cased based approach | Dr. Nikhil Patkar, Mumbai | ||
| Risk stratification and monitoring for patients treated with HMA + Ven | Dr. Rahul Bhargava, Gurugram | ||
| 12.00-1.00 PM | Session XVII: Session on CLPD/ Lymphoma Chair: Dr. Ajay Gogia, Delhi; Dr. Mehar Chand Sharma, Delhi; Dr. Balamurugan Thirunavukkarasu, Delhi, Dr. Ajay Sharma, Chandigarh Sponsor- Abbvie | ||
| Using MRD in low- and high-grade lymphoma for therapeutics. | Dr. Shivangi Harankhedkar, Bhubaneswar | ||
| Time-limited therapies in CLL- pros and cons | Dr. Pawan Kumar Singh, Delhi | ||
| 1.00-2.00 PM | Lunch | ||
| 2.00-3.00 PM | Session XVIII: Session on Hemophilia
Chair: Dr. Jyoti Kotwal, Delhi; Dr. Manas Kalra, Delhi, Dr. Sabina Langar, Delhi Sponsor-Novo Nordisk |
||
| Diagnostic Approach to Acquired Hemophilia | Dr. Preeti Tripathi, Delhi | ||
| EHL therapy: Role in the era of non-factor therapies | Dr. Varun Kaul, Faridkot | ||
| Emergency management of Hemophilia A with inhibitors- Inherited and Acquired |
Dr. Arihant Jain, Chandigarh |
||
| 3.00-3.55 PM | Session XIX: Session on Miscellaneous Chair: Dr. Pabitra Kumar Gogoi, Guwahati; Dr. Gaurav Dixit, Delhi; Dr. Soumyaranjan Mallick, Delhi Sponsor- Roche | ||
| Non-factor therapy- near normal life, Indian experiences | Dr. Sudhir Atri, Rohtak | ||
| Newer paradigms in the therapy of newly diagnosed DLBCL | Dr. Rohan Halder, Delhi | ||
| 03.55 – 5:00 PM | Session XX: Coagulation and bleeding Chair: Dr. Linda Marangmei, Imphal; Dr. Meera Sikka, Delhi; Dr. Richa Gupta, Delhi Sponsor- Zydus | ||
| Molecular Aspect of Immune Thrombocytopenia | Dr. Meghnathan Kannan, Chennai | ||
| Immune thrombocytopenia- Choosing second line and beyond | Dr. Shailendra Prasad Verma, Lucknow | ||
| Thrombo-inflammation and regeneration- bench side for hematologists | Dr. Jasmina Ahluwalia, Chandigarh | ||
| 5.00 PM |
Vote of thanks & break |
||
• Central Line Insertions and Care
• Consultative Hematology
• Quality Control
• Flow Cytometry
• Hemostasis
• Nursing CME on Hematology patient care
• Medical lab technologists, CME in Hematology lab.
Note: Delegates / Medical technologists can also register for QC workshop in addition to one of the above mentioned workshops/CME
About us
Programs
Workshops
Organizing Committee
Speakers
Registration Details
© 2024 Department of Hematology, AIIMS. All Rights Reserved.
